Gene Therapy
We believe the curative potential of gene therapies is enormous, particularly in the battle against rare and genetic diseases. With 350+ clinical trials active and more preclinical innovation underway, there’s a clear opportunity to offer meaningful treatments to patients with significant unmet need.
Our Gene Therapy products help you tackle the most challenging problems, from safety and quality concerns relating to dose and vector type, to manufacturing bottlenecks and navigating the evolving regulatory landscape.
Delivering Safer, More Effective, & Globally Accessible Gene Therapies to Patients
Several gene therapies are now commercially approved across the U.S., Europe, and other markets, and now the field is rapidly evolving from rare disease solutions to broader applications in more common diseases, improving patient access and commercial viability of these treatments.
As of 2024, over 1100 gene therapy trials were recorded alongside a wave of preclinical innovation, gene therapy is on a path to transform how we treat disease at its root cause.
Our Gene Therapy products help you to stay on top of advances in the field—addressing key challenges like vector design and safety, manufacturing scalability, and ever-changing regulatory demands. Whether you’re advancing your first candidate or scaling for commercialization, we’re here to support your journey toward bringing lasting therapies to more patients than ever before.
Featured Gene Therapy Products
Beacon
Conferences
Intelligence
Gene Therapy Products by Type
Make Faster, Better Drug Development Decisions
Premium Insight and Meaningful Connections for Biopharma
Expert-driven, Life Science Market Intelligence Solutions
CONTACT US
Get in touch
We speak to hundreds of biopharmaceutical experts from industry and academia every day. We would love for you to be one of them. Contact us to discover how our events can accelerate your drug development.
Standard Form - Microbiome
"*" indicates required fields